β-ラクタム系抗生物質用酵素の世界市場レポート2025-2031

QY Research > レポート一覧 > 薬品及びサプリメント > β-ラクタム系抗生物質用酵素の世界市場レポート2025-2031

英文タイトル： Global Enzymes for β-lactam Antibiotics Market Outlook, In‑Depth Analysis & Forecast to 2031

レポートID：1209293
発表時期：2025-08-05
訪問回数：3
ページ数：152
レポート形式：PDF
レポート言語：英語、日本語
グラフ数：156
レポートカテゴリ：薬品及びサプリメント

販売価格（消費税別）

個人版
詳細
マルチユーザー版
詳細
企業版
詳細

価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=162.50円。
※米ドル表示価格+10％消費税。

英語版

日本語版

英語と日本語版

価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=162.50円。
※米ドル表示価格+10％消費税。

お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合，注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。但し、日本語版が必要な場合は、受注後8～10営業日となります。お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

概要

本報告書は、β-ラクタム系抗生物質用酵素の世界市場について、容量、生産量、収益、価格の概要を紹介します。2021年から2025年までの過去の市場収益/売上データ、2026年の予測データ、ならびに2032年までのCAGR（年平均成長率）予測を含む、世界市場動向の分析を提供します。本レポートは、メーカー、地域、製品種類、およびエンドユーザー産業の観点から、世界と主要地域の市場現状と将来性を研究したものです。世界と主要地域のトップメーカーを分析し、製品タイプおよびアプリケーション/エンドユーザー産業別にβ-ラクタム系抗生物質用酵素市場を分類しています。

本レポートでは、世界のβ-ラクタム系抗生物質用酵素市場の主要参加企業として、企業概要、販売数量、収益、価格、粗利益率、製品ポートフォリオ、地理的位置、主要な事業展開を以下のパラメータに基づいて紹介します。
本レポートはβ-ラクタム系抗生物質用酵素の主要生産者を調査するとともに、主要地域や国の消費状況も提供します。β-ラクタム系抗生物質用酵素の主要地域／国における将来の市場ポテンシャルを重点的に分析し、それに基づき、異なるセグメントおよびサブセグメントにおける市場の将来動向を予測しております。アメリカ、カナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、その他の国々について、各国データおよび市場価値分析を提供しております。
2021年から2032年までの期間について、タイプ別および用途別の売上高、収益、価格に基づくセグメントデータを分析します。

本研究に含まれる主な企業は以下の通りです：
MCE
Merck & Co.
Hangzhou Junfeng Bioengineering
Shanghai Kekai Biotech
Hangzhou Chuangke Biotech
Hunan Fulaige Biotech
Biolab
Fermenta Biotech Ltd.
Biosynth
Amicogen
Creative Enzymes
Crawford Wisdom International
MuseChem Chemicals

タイプ別市場セグメント：
β-lactamase
Penicillin Acylase
Other

用途別市場セグメント：
Cephalosporins
Penicillin and Its Derivatives
Monoamide Ring
Other

地域別の市場セグメント：
北米
アジア太平洋
欧州
中南米
中東・アフリカ

本レポートの詳細内容：
世界のβ-ラクタム系抗生物質用酵素市場の現状と将来展望を包括的に分析し、グローバル主要地域における開発動向の綿密な調査を通じて、企業様に包括的な市場分析を提示します。市場の全体像を把握するため、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいてβ-ラクタム系抗生物質用酵素市場を細分化しています。この分類と用途分析により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2021年から2026年までの実績と2032年までの予測として、メーカー別、地域別（地域レベル、国レベル）のβ-ラクタム系抗生物質用酵素生産量、成長率、市場シェアを調査しています。
二. 消費面では、β-ラクタム系抗生物質用酵素の売上高について、地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2021年から2026年まで、および2032年までの予測を対象とします。
三. 主要メーカーのβ-ラクタム系抗生物質用酵素売上高、収益、市場シェア、業界ランキングについて、2021年から2026年までのデータに焦点を当てています。世界のβ-ラクタム系抗生物質用酵素市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づく競争状況と市場ポジショニングの分析を行います。
四. 本β-ラクタム系抗生物質用酵素レポートは、関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立案するのに役立つ洞察を提供することを目的としています。売上高、成長動向、生産技術、用途、エンドユーザー産業に関する市場規模の詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。
章節目次：
第1章： β-ラクタム系抗生物質用酵素レポートの範囲、市場セグメント（タイプ別、用途別など）ごとの市場規模、将来の発展可能性などをまとめたエグゼクティブサマリーをご紹介いたします。これにより、市場の最新状況を包括的に把握し、短期・中期・長期（2021-2032年）にわたる発展の見通しを把握いただけます。
第2章： β-ラクタム系抗生物質用酵素の世界および主要生産者（地域／国別）の生産量／アウトプットについて分析します。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています（2021年～2032年）
第3章： β-ラクタム系抗生物質用酵素の現在の市場状況を提示し、2032年までの世界的な収益・販売・生産を予測するとともに、消費量の多い地域と新興市場の成長要因を特定します（2021年～2032年）
第4章： β-ラクタム系抗生物質用酵素メーカーの競争状況、価格、売上高、収益、市場シェア、業界ランキング、最新の開発計画、合併・買収情報など詳細に分析します（2021年～2026年）
第5章： β-ラクタム系抗生物質用酵素の下流市場機会を特定し、用途別販売量・収益・価格設定を評価するとともに新興ユースケースを明らかにし、地域別・用途別の主要顧客をプロファイリングします
第6章： β-ラクタム系抗生物質用酵素のグローバル生産能力、稼働率、市場シェア（2021-2032年）をマッピングし、効率的拠点を特定するとともに規制や貿易政策の影響とボトルネックを解明します
第7章：北米におけるβ-ラクタム系抗生物質用酵素市場をアプリケーション別・国別売上高・収益で分析し、主要メーカーをプロファイリングしつつ成長要因と障壁を評価します
第8章：欧州におけるβ-ラクタム系抗生物質用酵素市場をアプリケーション別・メーカー別に地域別売上高・収益・市場分析を行い、成長要因と障壁を明示します
第9章：アジア太平洋地域のβ-ラクタム系抗生物質用酵素市場を用途別・地域/国別の売上高と収益で定量化し、主要メーカーをプロファイリングするとともに高成長潜在地域を明らかにします
第10章：中南米におけるβ-ラクタム系抗生物質用酵素市場を用途別・国別売上高と収益で測定し、主要メーカーをプロファイリングするとともに投資機会と課題を特定します
第11章：中東・アフリカ地域のβ-ラクタム系抗生物質用酵素市場を用途別・国別に評価し、主要メーカーをプロファイリングするとともに投資見通しと市場障壁を概説します
第12章： β-ラクタム系抗生物質用酵素の主要メーカーの概要を提供し、製品説明、売上高、収益、価格、粗利益率、最近の事業拡大などの情報を整理するとともに、SWOT分析および戦略動向分析を行います
第13章： β-ラクタム系抗生物質用酵素のサプライチェーンを分析し、上流の原材料・供給業者、製造拠点と技術、コスト要因を明らかにします
第14章： β-ラクタム系抗生物質用酵素の市場動向、最新動向、推進要因と制約要因、業界内のメーカーが直面する課題とリスク、関連する業界政策の分析を紹介します
第15章：レポートの要点と結論
第16章：付録

Description

The global Enzymes for β-lactam Antibiotics market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

β-lactam antibiotics refer to a large class of antibiotics with a β-lactam ring in their chemical structure, including the most commonly used penicillins and cephalosporins in clinical practice, as well as other atypical β-lactam antibiotics such as the newly developed cephalomycins, thiomycins, and monocyclic β-lactams. This type of antibiotic has the advantages of strong bactericidal activity, low toxicity, wide indications, and good clinical efficacy.

From a downstream perspective, Cephalosporins accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

Enzymes for β-lactam Antibiotics leading manufacturers including MCE, Merck & Co., Hangzhou Junfeng Bioengineering, Shanghai Kekai Biotech, Hangzhou Chuangke Biotech, Hunan Fulaige Biotech, Biolab, Fermenta Biotech Ltd., Biosynth, Amicogen, etc., dominate supply; the top five capture approximately % of global revenue, with MCE leading 2024 sales at US$ million.

Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Enzymes for β-lactam Antibiotics market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation
By Company
MCE
Merck & Co.
Hangzhou Junfeng Bioengineering
Shanghai Kekai Biotech
Hangzhou Chuangke Biotech
Hunan Fulaige Biotech
Biolab
Fermenta Biotech Ltd.
Biosynth
Amicogen
Creative Enzymes
Crawford Wisdom International
MuseChem Chemicals

Segment by Type
β-lactamase
Penicillin Acylase
Other

Segment by Application
Cephalosporins
Penicillin and Its Derivatives
Monoamide Ring
Other

Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina

Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa

Chapter Outline
Chapter 1: Defines the Enzymes for β-lactam Antibiotics study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).

Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.

Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).

Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).

Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

Table of Contents

1 Study Coverage
1.1 Introduction to Enzymes for β-lactam Antibiotics: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Enzymes for β-lactam Antibiotics Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 β-lactamase
1.2.3 Penicillin Acylase
1.2.4 Other
1.3 Market Segmentation by Application
1.3.1 Global Enzymes for β-lactam Antibiotics Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Cephalosporins
1.3.3 Penicillin and Its Derivatives
1.3.4 Monoamide Ring
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Executive Summary
2.1 Global Enzymes for β-lactam Antibiotics Revenue Estimates and Forecasts 2020-2031
2.2 Global Enzymes for β-lactam Antibiotics Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Enzymes for β-lactam Antibiotics Sales Estimates and Forecasts 2020-2031
2.4 Global Enzymes for β-lactam Antibiotics Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)

3 Competition by Manufacturers
3.1 Global Enzymes for β-lactam Antibiotics Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Enzymes for β-lactam Antibiotics Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 β-lactamase Market Size by Manufacturers
3.5.2 Penicillin Acylase Market Size by Manufacturers
3.5.3 Other Market Size by Manufacturers
3.6 Global Enzymes for β-lactam Antibiotics Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Global Product Segmentation Analysis
4.1 Global Enzymes for β-lactam Antibiotics Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Enzymes for β-lactam Antibiotics Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats

5 Global Downstream Application Analysis
5.1 Global Enzymes for β-lactam Antibiotics Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Enzymes for β-lactam Antibiotics Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application

6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Enzymes for β-lactam Antibiotics Sales and Revenue by Type (2020-2031)
6.4 North America Enzymes for β-lactam Antibiotics Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Enzymes for β-lactam Antibiotics Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico

7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Enzymes for β-lactam Antibiotics Sales and Revenue by Type (2020-2031)
7.4 Europe Enzymes for β-lactam Antibiotics Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Enzymes for β-lactam Antibiotics Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia

8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Enzymes for β-lactam Antibiotics Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Enzymes for β-lactam Antibiotics Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Enzymes for β-lactam Antibiotics Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India

9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Enzymes for β-lactam Antibiotics Sales and Revenue by Type (2020-2031)
9.4 Central and South America Enzymes for β-lactam Antibiotics Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Enzymes for β-lactam Antibiotics Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Enzymes for β-lactam Antibiotics Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Enzymes for β-lactam Antibiotics Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Enzymes for β-lactam Antibiotics Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa

11 Corporate Profile
11.1 MCE
11.1.1 MCE Corporation Information
11.1.2 MCE Business Overview
11.1.3 MCE Enzymes for β-lactam Antibiotics Product Models, Descriptions and Specifications
11.1.4 MCE Enzymes for β-lactam Antibiotics Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 MCE Enzymes for β-lactam Antibiotics Sales by Product in 2024
11.1.6 MCE Enzymes for β-lactam Antibiotics Sales by Application in 2024
11.1.7 MCE Enzymes for β-lactam Antibiotics Sales by Geographic Area in 2024
11.1.8 MCE Enzymes for β-lactam Antibiotics SWOT Analysis
11.1.9 MCE Recent Developments
11.2 Merck & Co.
11.2.1 Merck & Co. Corporation Information
11.2.2 Merck & Co. Business Overview
11.2.3 Merck & Co. Enzymes for β-lactam Antibiotics Product Models, Descriptions and Specifications
11.2.4 Merck & Co. Enzymes for β-lactam Antibiotics Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Merck & Co. Enzymes for β-lactam Antibiotics Sales by Product in 2024
11.2.6 Merck & Co. Enzymes for β-lactam Antibiotics Sales by Application in 2024
11.2.7 Merck & Co. Enzymes for β-lactam Antibiotics Sales by Geographic Area in 2024
11.2.8 Merck & Co. Enzymes for β-lactam Antibiotics SWOT Analysis
11.2.9 Merck & Co. Recent Developments
11.3 Hangzhou Junfeng Bioengineering
11.3.1 Hangzhou Junfeng Bioengineering Corporation Information
11.3.2 Hangzhou Junfeng Bioengineering Business Overview
11.3.3 Hangzhou Junfeng Bioengineering Enzymes for β-lactam Antibiotics Product Models, Descriptions and Specifications
11.3.4 Hangzhou Junfeng Bioengineering Enzymes for β-lactam Antibiotics Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Hangzhou Junfeng Bioengineering Enzymes for β-lactam Antibiotics Sales by Product in 2024
11.3.6 Hangzhou Junfeng Bioengineering Enzymes for β-lactam Antibiotics Sales by Application in 2024
11.3.7 Hangzhou Junfeng Bioengineering Enzymes for β-lactam Antibiotics Sales by Geographic Area in 2024
11.3.8 Hangzhou Junfeng Bioengineering Enzymes for β-lactam Antibiotics SWOT Analysis
11.3.9 Hangzhou Junfeng Bioengineering Recent Developments
11.4 Shanghai Kekai Biotech
11.4.1 Shanghai Kekai Biotech Corporation Information
11.4.2 Shanghai Kekai Biotech Business Overview
11.4.3 Shanghai Kekai Biotech Enzymes for β-lactam Antibiotics Product Models, Descriptions and Specifications
11.4.4 Shanghai Kekai Biotech Enzymes for β-lactam Antibiotics Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Shanghai Kekai Biotech Enzymes for β-lactam Antibiotics Sales by Product in 2024
11.4.6 Shanghai Kekai Biotech Enzymes for β-lactam Antibiotics Sales by Application in 2024
11.4.7 Shanghai Kekai Biotech Enzymes for β-lactam Antibiotics Sales by Geographic Area in 2024
11.4.8 Shanghai Kekai Biotech Enzymes for β-lactam Antibiotics SWOT Analysis
11.4.9 Shanghai Kekai Biotech Recent Developments
11.5 Hangzhou Chuangke Biotech
11.5.1 Hangzhou Chuangke Biotech Corporation Information
11.5.2 Hangzhou Chuangke Biotech Business Overview
11.5.3 Hangzhou Chuangke Biotech Enzymes for β-lactam Antibiotics Product Models, Descriptions and Specifications
11.5.4 Hangzhou Chuangke Biotech Enzymes for β-lactam Antibiotics Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Hangzhou Chuangke Biotech Enzymes for β-lactam Antibiotics Sales by Product in 2024
11.5.6 Hangzhou Chuangke Biotech Enzymes for β-lactam Antibiotics Sales by Application in 2024
11.5.7 Hangzhou Chuangke Biotech Enzymes for β-lactam Antibiotics Sales by Geographic Area in 2024
11.5.8 Hangzhou Chuangke Biotech Enzymes for β-lactam Antibiotics SWOT Analysis
11.5.9 Hangzhou Chuangke Biotech Recent Developments
11.6 Hunan Fulaige Biotech
11.6.1 Hunan Fulaige Biotech Corporation Information
11.6.2 Hunan Fulaige Biotech Business Overview
11.6.3 Hunan Fulaige Biotech Enzymes for β-lactam Antibiotics Product Models, Descriptions and Specifications
11.6.4 Hunan Fulaige Biotech Enzymes for β-lactam Antibiotics Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Hunan Fulaige Biotech Recent Developments
11.7 Biolab
11.7.1 Biolab Corporation Information
11.7.2 Biolab Business Overview
11.7.3 Biolab Enzymes for β-lactam Antibiotics Product Models, Descriptions and Specifications
11.7.4 Biolab Enzymes for β-lactam Antibiotics Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Biolab Recent Developments
11.8 Fermenta Biotech Ltd.
11.8.1 Fermenta Biotech Ltd. Corporation Information
11.8.2 Fermenta Biotech Ltd. Business Overview
11.8.3 Fermenta Biotech Ltd. Enzymes for β-lactam Antibiotics Product Models, Descriptions and Specifications
11.8.4 Fermenta Biotech Ltd. Enzymes for β-lactam Antibiotics Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Fermenta Biotech Ltd. Recent Developments
11.9 Biosynth
11.9.1 Biosynth Corporation Information
11.9.2 Biosynth Business Overview
11.9.3 Biosynth Enzymes for β-lactam Antibiotics Product Models, Descriptions and Specifications
11.9.4 Biosynth Enzymes for β-lactam Antibiotics Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Biosynth Recent Developments
11.10 Amicogen
11.10.1 Amicogen Corporation Information
11.10.2 Amicogen Business Overview
11.10.3 Amicogen Enzymes for β-lactam Antibiotics Product Models, Descriptions and Specifications
11.10.4 Amicogen Enzymes for β-lactam Antibiotics Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Amicogen Recent Developments
11.11 Creative Enzymes
11.11.1 Creative Enzymes Corporation Information
11.11.2 Creative Enzymes Business Overview
11.11.3 Creative Enzymes Enzymes for β-lactam Antibiotics Product Models, Descriptions and Specifications
11.11.4 Creative Enzymes Enzymes for β-lactam Antibiotics Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Creative Enzymes Recent Developments
11.12 Crawford Wisdom International
11.12.1 Crawford Wisdom International Corporation Information
11.12.2 Crawford Wisdom International Business Overview
11.12.3 Crawford Wisdom International Enzymes for β-lactam Antibiotics Product Models, Descriptions and Specifications
11.12.4 Crawford Wisdom International Enzymes for β-lactam Antibiotics Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Crawford Wisdom International Recent Developments
11.13 MuseChem Chemicals
11.13.1 MuseChem Chemicals Corporation Information
11.13.2 MuseChem Chemicals Business Overview
11.13.3 MuseChem Chemicals Enzymes for β-lactam Antibiotics Product Models, Descriptions and Specifications
11.13.4 MuseChem Chemicals Enzymes for β-lactam Antibiotics Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 MuseChem Chemicals Recent Developments

12 Value Chain and Supply-Chain Analysis
12.1 Enzymes for β-lactam Antibiotics Industry Chain
12.2 Enzymes for β-lactam Antibiotics Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Enzymes for β-lactam Antibiotics Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Enzymes for β-lactam Antibiotics Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors

13 Enzymes for β-lactam Antibiotics Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Enzymes for β-lactam Antibiotics Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details

Table of Figures

List of Tables
 Table 1. Global Enzymes for β-lactam Antibiotics Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Enzymes for β-lactam Antibiotics Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Enzymes for β-lactam Antibiotics Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Enzymes for β-lactam Antibiotics Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Enzymes for β-lactam Antibiotics Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Enzymes for β-lactam Antibiotics Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Dose)
 Table 7. Global Enzymes for β-lactam Antibiotics Sales by Region (2020-2025) & (K Dose)
 Table 8. Global Enzymes for β-lactam Antibiotics Sales by Region (2026-2031) & (K Dose)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Enzymes for β-lactam Antibiotics Sales by Manufacturers (2020-2025) & (K Dose)
 Table 11. Global Enzymes for β-lactam Antibiotics Sales Share by Manufacturers (2020-2025)
 Table 12. Global Enzymes for β-lactam Antibiotics Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Enzymes for β-lactam Antibiotics Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Enzymes for β-lactam Antibiotics by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enzymes for β-lactam Antibiotics as of 2024)
 Table 16. Global Enzymes for β-lactam Antibiotics Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Enzymes for β-lactam Antibiotics Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Dose)
 Table 18. Key Manufacturers Enzymes for β-lactam Antibiotics Manufacturing Base and Headquarters
 Table 19. Global Enzymes for β-lactam Antibiotics Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Enzymes for β-lactam Antibiotics Sales by Type (2020-2025) & (K Dose)
 Table 23. Global Enzymes for β-lactam Antibiotics Sales by Type (2026-2031) & (K Dose)
 Table 24. Global Enzymes for β-lactam Antibiotics Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Enzymes for β-lactam Antibiotics Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Enzymes for β-lactam Antibiotics ASP by Type (2020-2031) & (US$/Dose)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Enzymes for β-lactam Antibiotics Sales by Application (2020-2025) & (K Dose)
 Table 29. Global Enzymes for β-lactam Antibiotics Sales by Application (2026-2031) & (K Dose)
 Table 30. Enzymes for β-lactam Antibiotics High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Enzymes for β-lactam Antibiotics Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Enzymes for β-lactam Antibiotics Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Enzymes for β-lactam Antibiotics ASP by Application (2020-2031) & (US$/Dose)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Enzymes for β-lactam Antibiotics Growth Accelerators and Market Barriers
 Table 37. North America Enzymes for β-lactam Antibiotics Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Enzymes for β-lactam Antibiotics Sales (K Dose) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Enzymes for β-lactam Antibiotics Growth Accelerators and Market Barriers
 Table 40. Europe Enzymes for β-lactam Antibiotics Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Enzymes for β-lactam Antibiotics Sales (K Dose) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Enzymes for β-lactam Antibiotics Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Enzymes for β-lactam Antibiotics Sales (K Dose) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Enzymes for β-lactam Antibiotics Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Enzymes for β-lactam Antibiotics Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Enzymes for β-lactam Antibiotics Investment Opportunities and Key Challenges
 Table 47. Central and South America Enzymes for β-lactam Antibiotics Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Enzymes for β-lactam Antibiotics Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Enzymes for β-lactam Antibiotics Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. MCE Corporation Information
 Table 51. MCE Description and Major Businesses
 Table 52. MCE Product Models, Descriptions and Specifications
 Table 53. MCE Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 54. MCE Sales Value Proportion by Product in 2024
 Table 55. MCE Sales Value Proportion by Application in 2024
 Table 56. MCE Sales Value Proportion by Geographic Area in 2024
 Table 57. MCE Enzymes for β-lactam Antibiotics SWOT Analysis
 Table 58. MCE Recent Developments
 Table 59. Merck & Co. Corporation Information
 Table 60. Merck & Co. Description and Major Businesses
 Table 61. Merck & Co. Product Models, Descriptions and Specifications
 Table 62. Merck & Co. Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 63. Merck & Co. Sales Value Proportion by Product in 2024
 Table 64. Merck & Co. Sales Value Proportion by Application in 2024
 Table 65. Merck & Co. Sales Value Proportion by Geographic Area in 2024
 Table 66. Merck & Co. Enzymes for β-lactam Antibiotics SWOT Analysis
 Table 67. Merck & Co. Recent Developments
 Table 68. Hangzhou Junfeng Bioengineering Corporation Information
 Table 69. Hangzhou Junfeng Bioengineering Description and Major Businesses
 Table 70. Hangzhou Junfeng Bioengineering Product Models, Descriptions and Specifications
 Table 71. Hangzhou Junfeng Bioengineering Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 72. Hangzhou Junfeng Bioengineering Sales Value Proportion by Product in 2024
 Table 73. Hangzhou Junfeng Bioengineering Sales Value Proportion by Application in 2024
 Table 74. Hangzhou Junfeng Bioengineering Sales Value Proportion by Geographic Area in 2024
 Table 75. Hangzhou Junfeng Bioengineering Enzymes for β-lactam Antibiotics SWOT Analysis
 Table 76. Hangzhou Junfeng Bioengineering Recent Developments
 Table 77. Shanghai Kekai Biotech Corporation Information
 Table 78. Shanghai Kekai Biotech Description and Major Businesses
 Table 79. Shanghai Kekai Biotech Product Models, Descriptions and Specifications
 Table 80. Shanghai Kekai Biotech Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 81. Shanghai Kekai Biotech Sales Value Proportion by Product in 2024
 Table 82. Shanghai Kekai Biotech Sales Value Proportion by Application in 2024
 Table 83. Shanghai Kekai Biotech Sales Value Proportion by Geographic Area in 2024
 Table 84. Shanghai Kekai Biotech Enzymes for β-lactam Antibiotics SWOT Analysis
 Table 85. Shanghai Kekai Biotech Recent Developments
 Table 86. Hangzhou Chuangke Biotech Corporation Information
 Table 87. Hangzhou Chuangke Biotech Description and Major Businesses
 Table 88. Hangzhou Chuangke Biotech Product Models, Descriptions and Specifications
 Table 89. Hangzhou Chuangke Biotech Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 90. Hangzhou Chuangke Biotech Sales Value Proportion by Product in 2024
 Table 91. Hangzhou Chuangke Biotech Sales Value Proportion by Application in 2024
 Table 92. Hangzhou Chuangke Biotech Sales Value Proportion by Geographic Area in 2024
 Table 93. Hangzhou Chuangke Biotech Enzymes for β-lactam Antibiotics SWOT Analysis
 Table 94. Hangzhou Chuangke Biotech Recent Developments
 Table 95. Hunan Fulaige Biotech Corporation Information
 Table 96. Hunan Fulaige Biotech Description and Major Businesses
 Table 97. Hunan Fulaige Biotech Product Models, Descriptions and Specifications
 Table 98. Hunan Fulaige Biotech Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 99. Hunan Fulaige Biotech Recent Developments
 Table 100. Biolab Corporation Information
 Table 101. Biolab Description and Major Businesses
 Table 102. Biolab Product Models, Descriptions and Specifications
 Table 103. Biolab Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 104. Biolab Recent Developments
 Table 105. Fermenta Biotech Ltd. Corporation Information
 Table 106. Fermenta Biotech Ltd. Description and Major Businesses
 Table 107. Fermenta Biotech Ltd. Product Models, Descriptions and Specifications
 Table 108. Fermenta Biotech Ltd. Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 109. Fermenta Biotech Ltd. Recent Developments
 Table 110. Biosynth Corporation Information
 Table 111. Biosynth Description and Major Businesses
 Table 112. Biosynth Product Models, Descriptions and Specifications
 Table 113. Biosynth Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 114. Biosynth Recent Developments
 Table 115. Amicogen Corporation Information
 Table 116. Amicogen Description and Major Businesses
 Table 117. Amicogen Product Models, Descriptions and Specifications
 Table 118. Amicogen Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 119. Amicogen Recent Developments
 Table 120. Creative Enzymes Corporation Information
 Table 121. Creative Enzymes Description and Major Businesses
 Table 122. Creative Enzymes Product Models, Descriptions and Specifications
 Table 123. Creative Enzymes Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 124. Creative Enzymes Recent Developments
 Table 125. Crawford Wisdom International Corporation Information
 Table 126. Crawford Wisdom International Description and Major Businesses
 Table 127. Crawford Wisdom International Product Models, Descriptions and Specifications
 Table 128. Crawford Wisdom International Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 129. Crawford Wisdom International Recent Developments
 Table 130. MuseChem Chemicals Corporation Information
 Table 131. MuseChem Chemicals Description and Major Businesses
 Table 132. MuseChem Chemicals Product Models, Descriptions and Specifications
 Table 133. MuseChem Chemicals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 134. MuseChem Chemicals Recent Developments
 Table 135. Key Raw Materials Distribution
 Table 136. Raw Materials Key Suppliers
 Table 137. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 138. Milestones in Production Technology Evolution
 Table 139. Distributors List
 Table 140. Market Trends and Market Evolution
 Table 141. Market Drivers and Opportunities
 Table 142. Market Challenges, Risks, and Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources


List of Figures
 Figure 1. Enzymes for β-lactam Antibiotics Product Picture
 Figure 2. Global Enzymes for β-lactam Antibiotics Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. β-lactamase Product Picture
 Figure 4. Penicillin Acylase Product Picture
 Figure 5. Other Product Picture
 Figure 6. Global Enzymes for β-lactam Antibiotics Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Cephalosporins
 Figure 8. Penicillin and Its Derivatives
 Figure 9. Monoamide Ring
 Figure 10. Other
 Figure 11. Enzymes for β-lactam Antibiotics Report Years Considered
 Figure 12. Global Enzymes for β-lactam Antibiotics Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Enzymes for β-lactam Antibiotics Revenue (2020-2031) & (US$ Million)
 Figure 14. Global Enzymes for β-lactam Antibiotics Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 15. Global Enzymes for β-lactam Antibiotics Revenue Market Share by Region (2020-2031)
 Figure 16. Global Enzymes for β-lactam Antibiotics Sales (2020-2031) & (K Dose)
 Figure 17. Global Enzymes for β-lactam Antibiotics Sales (CAGR) by Region (2020-2031) (K Dose)
 Figure 18. Global Enzymes for β-lactam Antibiotics Sales Market Share by Region (2020-2031)
 Figure 19. Top 5 and Top 10 Manufacturers Enzymes for β-lactam Antibiotics Sales Volume Market Share in 2024
 Figure 20. Global Enzymes for β-lactam Antibiotics Revenue Market Share Ranking (2024)
 Figure 21. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 22. β-lactamase Revenue Market Share by Manufacturer in 2024
 Figure 23. Penicillin Acylase Revenue Market Share by Manufacturer in 2024
 Figure 24. Other Revenue Market Share by Manufacturer in 2024
 Figure 25. Global Enzymes for β-lactam Antibiotics Sales Market Share by Type (2020-2031)
 Figure 26. Global Enzymes for β-lactam Antibiotics Revenue Market Share by Type (2020-2031)
 Figure 27. Global Enzymes for β-lactam Antibiotics Sales Market Share by Application (2020-2031)
 Figure 28. Global Enzymes for β-lactam Antibiotics Revenue Market Share by Application (2020-2031)
 Figure 29. North America Enzymes for β-lactam Antibiotics Sales YoY (2020-2031) & (K Dose)
 Figure 30. North America Enzymes for β-lactam Antibiotics Revenue YoY (2020-2031) & (US$ Million)
 Figure 31. North America Top 5 Manufacturers Enzymes for β-lactam Antibiotics Sales Revenue (US$ Million) in 2024
 Figure 32. North America Enzymes for β-lactam Antibiotics Sales Volume (K Dose) by Type (2020- 2031)
 Figure 33. North America Enzymes for β-lactam Antibiotics Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 34. North America Enzymes for β-lactam Antibiotics Sales Volume (K Dose) by Application (2020-2031)
 Figure 35. North America Enzymes for β-lactam Antibiotics Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 36. US Enzymes for β-lactam Antibiotics Revenue (2020-2031) & (US$ Million)
 Figure 37. Canada Enzymes for β-lactam Antibiotics Revenue (2020-2031) & (US$ Million)
 Figure 38. Mexico Enzymes for β-lactam Antibiotics Revenue (2020-2031) & (US$ Million)
 Figure 39. Europe Enzymes for β-lactam Antibiotics Sales YoY (2020-2031) & (K Dose)
 Figure 40. Europe Enzymes for β-lactam Antibiotics Revenue YoY (2020-2031) & (US$ Million)
 Figure 41. Europe Top 5 Manufacturers Enzymes for β-lactam Antibiotics Sales Revenue (US$ Million) in 2024
 Figure 42. Europe Enzymes for β-lactam Antibiotics Sales Volume (K Dose) by Type (2020-2031)
 Figure 43. Europe Enzymes for β-lactam Antibiotics Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 44. Europe Enzymes for β-lactam Antibiotics Sales Volume (K Dose) by Application (2020-2031)
 Figure 45. Europe Enzymes for β-lactam Antibiotics Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 46. Germany Enzymes for β-lactam Antibiotics Revenue (2020-2031) & (US$ Million)
 Figure 47. France Enzymes for β-lactam Antibiotics Revenue (2020-2031) & (US$ Million)
 Figure 48. U.K. Enzymes for β-lactam Antibiotics Revenue (2020-2031) & (US$ Million)
 Figure 49. Italy Enzymes for β-lactam Antibiotics Revenue (2020-2031) & (US$ Million)
 Figure 50. Russia Enzymes for β-lactam Antibiotics Revenue (2020-2031) & (US$ Million)
 Figure 51. Asia-Pacific Enzymes for β-lactam Antibiotics Sales YoY (2020-2031) & (K Dose)
 Figure 52. Asia-Pacific Enzymes for β-lactam Antibiotics Revenue YoY (2020-2031) & (US$ Million)
 Figure 53. Asia-Pacific Top 8 Manufacturers Enzymes for β-lactam Antibiotics Sales Revenue (US$ Million) in 2024
 Figure 54. Asia-Pacific Enzymes for β-lactam Antibiotics Sales Volume (K Dose) by Type (2020- 2031)
 Figure 55. Asia-Pacific Enzymes for β-lactam Antibiotics Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 56. Asia-Pacific Enzymes for β-lactam Antibiotics Sales Volume (K Dose) by Application (2020-2031)
 Figure 57. Asia-Pacific Enzymes for β-lactam Antibiotics Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 58. Indonesia Enzymes for β-lactam Antibiotics Revenue (2020-2031) & (US$ Million)
 Figure 59. Japan Enzymes for β-lactam Antibiotics Revenue (2020-2031) & (US$ Million)
 Figure 60. South Korea Enzymes for β-lactam Antibiotics Revenue (2020-2031) & (US$ Million)
 Figure 61. China Taiwan Enzymes for β-lactam Antibiotics Revenue (2020-2031) & (US$ Million)
 Figure 62. India Enzymes for β-lactam Antibiotics Revenue (2020-2031) & (US$ Million)
 Figure 63. Central and South America Enzymes for β-lactam Antibiotics Sales YoY (2020-2031) & (K Dose)
 Figure 64. Central and South America Enzymes for β-lactam Antibiotics Revenue YoY (2020-2031) & (US$ Million)
 Figure 65. Central and South America Top 5 Manufacturers Enzymes for β-lactam Antibiotics Sales Revenue (US$ Million) in 2024
 Figure 66. Central and South America Enzymes for β-lactam Antibiotics Sales Volume (K Dose) by Type (2021-2031)
 Figure 67. Central and South America Enzymes for β-lactam Antibiotics Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 68. Central and South America Enzymes for β-lactam Antibiotics Sales Volume (K Dose) by Application (2020-2031)
 Figure 69. Central and South America Enzymes for β-lactam Antibiotics Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 70. Brazil Enzymes for β-lactam Antibiotics Revenue (2020-2025) & (US$ Million)
 Figure 71. Argentina Enzymes for β-lactam Antibiotics Revenue (2020-2025) & (US$ Million)
 Figure 72. Middle East, and Africa Enzymes for β-lactam Antibiotics Sales YoY (2020-2031) & (K Dose)
 Figure 73. Middle East and Africa Enzymes for β-lactam Antibiotics Revenue YoY (2020-2031) & (US$ Million)
 Figure 74. Middle East and Africa Top 5 Manufacturers Enzymes for β-lactam Antibiotics Sales Revenue (US$ Million) in 2024
 Figure 75. Middle East and Africa Enzymes for β-lactam Antibiotics Sales Volume (K Dose) by Type (2021-2031)
 Figure 76. South America Enzymes for β-lactam Antibiotics Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 77. Middle East and Africa Enzymes for β-lactam Antibiotics Sales Volume (K Dose) by Application (2020-2031)
 Figure 78. Middle East and Africa Enzymes for β-lactam Antibiotics Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 79. GCC Countries Enzymes for β-lactam Antibiotics Revenue (2020-2025) & (US$ Million)
 Figure 80. Turkey Enzymes for β-lactam Antibiotics Revenue (2020-2025) & (US$ Million)
 Figure 81. Egypt Enzymes for β-lactam Antibiotics Revenue (2020-2025) & (US$ Million)
 Figure 82. South Africa Enzymes for β-lactam Antibiotics Revenue (2020-2025) & (US$ Million)
 Figure 83. Enzymes for β-lactam Antibiotics Industry Chain Mapping
 Figure 84. Regional Enzymes for β-lactam Antibiotics Manufacturing Base Distribution (%)
 Figure 85. Global Enzymes for β-lactam Antibiotics Production Market Share by Region (2020-2031)
 Figure 86. Enzymes for β-lactam Antibiotics Production Process
 Figure 87. Regional Enzymes for β-lactam Antibiotics Production Cost Structure
 Figure 88. Channels of Distribution (Direct Vs Distribution)
 Figure 89. Bottom-up and Top-down Approaches for This Report
 Figure 90. Data Triangulation
 Figure 91. Key Executives Interviewed

以下、関連資料のご紹介